COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by slagheapon Nov 22, 2015 2:20pm

99 Views

Post# 24313943

RE:RE:RE:RE:RE:Maybe Martin Shkreli can help AZ...

Talking AEZS...their cash position is arounf $6 per...support is $4...200 day ave is $4.50...the potential success of their lead candidate could return them to the pre-financing range - $60 - if the market sees it that way

With a tight float it would be difficult to take a position with any certainty of a buy-in price. If they are really confident of the phase 3 approval they might be going private if they think they are looking at a billion dollar market.

Bullboard Posts

How Canadian investors can benefit from flow-through shares